Walmart has agreed to a $50 million settlement after the DOJ and DEA accused its pharmacies of illegally filling thousands of opioid and controlled substance prescriptions since 2013. The complaint alleges Walmart pharmacists knowingly filled invalid prescriptions and ignored red flags, while the compliance team prioritized sales over legal obligations. As part of the settlement, Walmart must establish a hotline for reporting illegal activity and monitor pharmacy dispensing patterns to prevent future violations. This case highlights ongoing government efforts to hold pharmacies accountable amid the opioid crisis.
Walmart's stock dropped 10% in a month after its fiscal Q2 2027 earnings report, despite beating revenue expectations and raising its full-year outlook. The company saw a 23% surge in e-commerce and growth in membership and advertising revenues, but ...
Walmart's stock fell about 12% since May despite reporting better-than-expected Q2 earnings and raising full-year guidance. The selloff was driven by cautious Q3 guidance due to tariff refund reinvestments and pharmacy pricing pressures. However, Wal...
In 2026, Walmart and Sam's Club raised over $39 million through their annual fundraising campaign supporting Children's Miracle Network hospitals. The funds will enhance local children's hospitals by expanding access to specialized care, advanced equ...
Kohl's, McDonald's, and Walmart report earnings that reveal struggles among low-income consumers, indicating a recession already affecting half of Americans living paycheck to paycheck. Despite Kohl's slight revenue drop and tariff refunds, the broad...
Walmart's stock fell 10.5% following its fiscal Q2 2027 earnings report, trading below key moving averages. The company reported a 6% increase in sales, but inventory grew faster at 7% year-over-year, signaling weaker customer traffic. This is notabl...
